| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.036 | 0.4 |